• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

犬特应性皮炎皮损指数的开发与验证,一种用于快速评估犬特应性皮炎皮损严重程度的量表。

Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.

作者信息

Plant Jon D, Gortel Kinga, Kovalik Marcel, Polissar Nayak L, Neradilek Moni B

机构信息

SkinVet Clinic, Lake Oswego, OR 97035, USA.

出版信息

Vet Dermatol. 2012 Dec;23(6):515-e103. doi: 10.1111/j.1365-3164.2012.01113.x.

DOI:10.1111/j.1365-3164.2012.01113.x
PMID:23140318
Abstract

BACKGROUND

The third iteration of the Canine Atopic Dermatitis Extent and Severity Index (CADESI-03) is the only tool rigorously validated for canine atopic dermatitis (CAD) lesion scoring. The CADESI-03 requires 248 evaluations, limiting its widespread use.

HYPOTHESIS/OBJECTIVES: The goal of the study was to develop and validate a practical method of grading CAD lesions that requires scoring only the frequently affected body regions.

ANIMALS

Fifty-seven privately owned atopic dogs were used in the study.

METHODS

The Canine Atopic Dermatitis Lesion Index (CADLI) was evaluated in an open, multicentre reliability study. Validity was assessed with expert opinion (content validity) and comparison of CADLI with existing disease severity measures (construct and criterion validity). Reliability was evaluated by analysing repeated observations of each dog. Convenience was assessed in terms of the time required to complete the scale.

RESULTS

The CADLI scores correlated with overall assessment scores (r = 0.60, P < 0.001, linear mixed model) and pruritus severity scores (r = 0.53, P < 0.001, linear mixed model), establishing construct validity. The CADLI was strongly correlated with CADESI-03 (r = 0.84, P < 0.001, linear mixed model), establishing criterion validity. The CADLI values obtained by two observers correlated very strongly (r = 0.91, P < 0.001), as did the repeat values for the same observer (r = 0.98, P < 0.001). The mean time to complete the CADLI was less than that required for CADESI-03 (1.9 and 12.6 min, respectively), a highly significant difference (P < 0.001).

CONCLUSION AND CLINICAL IMPORTANCE

The CADLI was found to be an effective measure of CAD lesion severity, strongly correlating with CADESI-03. The convenience of CADLI makes it suitable for use in both clinical research and practice.

摘要

背景

犬特应性皮炎范围和严重程度指数(CADESI - 03)的第三次修订版是唯一经过严格验证的用于犬特应性皮炎(CAD)皮损评分的工具。CADESI - 03需要进行248次评估,限制了其广泛应用。

假设/目标:本研究的目的是开发并验证一种实用的CAD皮损分级方法,该方法仅需对经常受累的身体部位进行评分。

动物

57只私人饲养的特应性犬用于本研究。

方法

在一项开放性多中心可靠性研究中对犬特应性皮炎皮损指数(CADLI)进行评估。通过专家意见评估效度(内容效度),并将CADLI与现有疾病严重程度指标进行比较评估效度(结构效度和标准效度)。通过分析对每只犬的重复观察来评估信度。根据完成该量表所需时间评估便利性。

结果

CADLI评分与总体评估评分相关(r = 0.60,P < 0.001,线性混合模型)以及瘙痒严重程度评分相关(r = 0.53,P < 0.001,线性混合模型),确立了结构效度。CADLI与CADESI - 03高度相关(r = 0.84,P < 0.001,线性混合模型),确立了标准效度。两位观察者获得的CADLI值相关性非常强(r = 0.9,1,P < 0.001),同一观察者的重复值也是如此(r = 0.98,P < 0.001)。完成CADLI的平均时间少于CADESI - 03所需时间(分别为1.9分钟和12.6分钟),差异极显著(P < 0.001)。

结论及临床意义

发现CADLI是一种有效的CAD皮损严重程度测量方法,与CADESI - 03高度相关。CADLI的便利性使其适用于临床研究和实践。

相似文献

1
Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.犬特应性皮炎皮损指数的开发与验证,一种用于快速评估犬特应性皮炎皮损严重程度的量表。
Vet Dermatol. 2012 Dec;23(6):515-e103. doi: 10.1111/j.1365-3164.2012.01113.x.
2
Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.犬特应性皮炎范围和严重程度指数(CADESI)-4的验证,这是一种用于评估犬特应性皮炎皮肤病变的简化严重程度量表。
Vet Dermatol. 2014 Apr;25(2):77-85, e25. doi: 10.1111/vde.12107. Epub 2014 Jan 25.
3
Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.CADESI-03的验证,这是一种用于招募特应性皮炎犬只的临床试验严重程度量表。
Vet Dermatol. 2007 Apr;18(2):78-86. doi: 10.1111/j.1365-3164.2007.00569.x.
4
Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.确定犬特应性皮炎严重程度增加时的CADESI-03阈值。
Vet Dermatol. 2008 Jun;19(3):115-9. doi: 10.1111/j.1365-3164.2008.00668.x.
5
Development and validation of a graphic 2D investigator's global assessment instrument for grading the overall severity of atopic dermatitis in dogs.一种用于评估犬特应性皮炎总体严重程度分级的二维图形研究者整体评估工具的开发与验证
Vet Dermatol. 2020 Jun;31(3):207-e43. doi: 10.1111/vde.12824. Epub 2019 Dec 12.
6
Comparable efficacy of a topical 0.0584% hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis.外用0.0584%哈西奈德喷雾与口服环孢素治疗犬异位性皮炎的疗效相当。
Vet Dermatol. 2012 Feb;23(1):4-10, e1-2. doi: 10.1111/j.1365-3164.2011.00992.x. Epub 2011 Jul 1.
7
Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.免疫刺激脂质体-核酸复合物在难治性特应性皮炎犬过敏原特异性免疫治疗中的应用——一项初步研究。
Vet Dermatol. 2005 Feb;16(1):61-8. doi: 10.1111/j.1365-3164.2005.00426.x.
8
Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study.富含必需脂肪酸的饮食对犬特应性皮炎的疗效:一项随机、单盲、交叉研究。
Vet Dermatol. 2008 Jun;19(3):156-62. doi: 10.1111/j.1365-3164.2008.00670.x.
9
Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis? A compilation of studies.犬特应性皮炎中经表皮水分流失与临床症状相关吗?研究综述。
Vet Dermatol. 2012 Jun;23(3):238-e49. doi: 10.1111/j.1365-3164.2012.01055.x.
10
Efficacy of a 0.0584% hydrocortisone aceponate spray in the management of canine atopic dermatitis: a randomised, double blind, placebo-controlled trial.0.0584%醋酸氢化可的松喷雾剂治疗犬异位性皮炎的疗效:一项随机、双盲、安慰剂对照试验
Vet Dermatol. 2009 Jun;20(3):191-8. doi: 10.1111/j.1365-3164.2009.00756.x. Epub 2009 Apr 3.

引用本文的文献

1
Effects of a Protocol Combining a Non-Irritating Shampoo and an Adelmidrol-Based Adsorbent Mousse on Seborrhoea and Other Signs and Symptoms Secondary to Canine Atopic Dermatitis: A Multicenter, Open-Label Uncontrolled Clinical Trial.一种结合无刺激性洗发水和基于阿德米多醇的吸附性慕斯的方案对犬异位性皮炎继发的脂溢性皮炎及其他体征和症状的影响:一项多中心、开放标签非对照临床试验
Vet Sci. 2024 May 21;11(6):229. doi: 10.3390/vetsci11060229.
2
Effect of Bacillus subtilis and Bacillus coagulans spores on induced allergic contact dermatitis in dogs.枯草芽孢杆菌和凝结芽孢杆菌孢子对诱导性犬接触性皮炎的影响。
Vet Med Sci. 2024 May;10(3):e1410. doi: 10.1002/vms3.1410.
3
Analysis of Intestinal Microbiota and Metabolic Pathways before and after a 2-Month-Long Hydrolyzed Fish and Rice Starch Hypoallergenic Diet Trial in Pruritic Dogs.
对瘙痒犬进行为期2个月的水解鱼和大米淀粉低敏饮食试验前后的肠道微生物群和代谢途径分析。
Vet Sci. 2023 Jul 21;10(7):478. doi: 10.3390/vetsci10070478.
4
Letter regarding "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United States" and "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United Kingdom": About misappropriating the COSCAD'18 for an unintended use.关于《成功通过营养控制与食物不良反应相关的瘙痒及临床症状:在美国犬类中进行的一项符合COSCAD'18标准的随机对照临床试验》及《成功通过营养控制与食物不良反应相关的瘙痒及临床症状:在英国犬类中进行的一项符合COSCAD'18标准的随机对照临床试验》的信件:关于将COSCAD'18用于非预期用途的问题。
J Vet Intern Med. 2021 Nov;35(6):2563-2564. doi: 10.1111/jvim.16302. Epub 2021 Oct 25.
5
Response to letter regarding "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in the United States" and "Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in the United Kingdom".对关于“成功通过营养控制搔抓及与食物不良反应相关的临床症状:在美国进行的一项符合COSCAD'18标准的随机对照临床试验”和“成功通过营养控制搔抓及与食物不良反应相关的临床症状:在英国进行的一项符合COSCAD'18标准的随机对照临床试验”的信件的回复
J Vet Intern Med. 2021 Nov;35(6):2565-2566. doi: 10.1111/jvim.16300. Epub 2021 Oct 25.
6
Local and Systemic Changes in Lipid Profile as Potential Biomarkers for Canine Atopic Dermatitis.作为犬特应性皮炎潜在生物标志物的血脂谱局部和全身变化
Metabolites. 2021 Sep 30;11(10):670. doi: 10.3390/metabo11100670.
7
Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United Kingdom.成功控制与食物不良反应相关的瘙痒和临床症状的营养干预:一项在英国针对犬的随机对照 COSCAD'18 依从性临床试验。
J Vet Intern Med. 2021 Jul;35(4):1893-1901. doi: 10.1111/jvim.16192. Epub 2021 Jun 11.
8
Successful nutritional control of scratching and clinical signs associated with adverse food reaction: A randomized controlled COSCAD'18 adherent clinical trial in dogs in the United States.成功控制与食物不良反应相关的瘙痒和临床症状的营养干预:一项在美国进行的、针对犬的、随机对照、COSCAID'18 依从性临床试验。
J Vet Intern Med. 2021 Jul;35(4):1884-1892. doi: 10.1111/jvim.16193. Epub 2021 Jun 11.
9
Expression of barrier proteins in the skin lesions and inflammatory cytokines in peripheral blood mononuclear cells of atopic dogs.特应性犬皮肤损伤中屏障蛋白的表达及外周血单个核细胞中炎症细胞因子。
Sci Rep. 2021 Jun 1;11(1):11418. doi: 10.1038/s41598-021-90992-z.
10
Impact of Nutritional Supplementation on Canine Dermatological Disorders.营养补充对犬类皮肤病的影响。
Vet Sci. 2020 Apr 3;7(2):38. doi: 10.3390/vetsci7020038.